封面
市场调查报告书
商品编码
1575361

运动障碍市场:按类型、治疗方法、给药途径、最终用户分类 - 全球预测 2025-2030

Dyskinesia Market by Type (Chorea, Levodopa-Induced Dyskinesia, Myoclonus), Treatment (Medications, Surgical Procedures, Therapies), Route of Administration, End User - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023 年运动障碍市场价值为 23.4 亿美元,预计到 2024 年将达到 25 亿美元,预计复合年增长率为 8.44%,到 2030 年将达到 41.3 亿美元。

运动障碍通常与帕金森氏症和类似疾病有关,是指肌肉的不自主、不规则或急动运动。其范围涵盖多种疾病,包括药物引起的运动障碍,主要与长期使用左旋多巴等药物有关。解决运动障碍的必要性源于它对患者生活品质的重大影响,因此调查和治疗至关重要。应用包括主要针对神经传导物质系统的药物和缓解症状的治疗设备。典型的最终使用领域包括医院、诊所和研究机构。神经系统疾病盛行率的上升、意识的提高以及医疗技术的进步推动了市场的成长。然而,不断上涨的治疗成本和与现有治疗方法相关的副作用是成长的主要挑战。个人化医疗和基因治疗的创新提供了一个有前景的发展途径,并且可以显着影响市场动态。目前的治疗机会在于开发非多巴胺能治疗方案和即时追踪症状的穿戴式监测技术。公司可以透过积极与研究机构伙伴关係并实施人工智慧主导的研究策略来开拓尖端治疗方法而受益。一项重要建议是投资综合临床试验,以证明新治疗方法的有效性和安全性。监管障碍和严格的核准流程等挑战往往会减缓新治疗方法进入市场的速度。此外,患者对治疗反应的异质性可能需要更个人化的方法并使标准化工作变得复杂。治疗方法的地理差异凸显了新兴市场接受治疗的重要性。完美的创新领域包括了解影响神经保护策略和神经退化的微生物与肠道​​相互作用。整体而言,运动障碍市场有望成长,特别是当新的创新解决现有限制时,但要充分发挥其潜力,需要从策略上克服固有的复杂性和挑战。

主要市场统计
基准年[2023] 23.4亿美元
预测年份 [2024] 25亿美元
预测年份 [2030] 41.3亿美元
复合年增长率(%) 8.44%

市场动态:揭示快速发展的运动障碍市场的关键市场洞察

供需的动态交互作用正在改变运动障碍市场。透过了解这些不断变化的市场动态,公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险,同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 製药公司与研究机构合作
    • 透过增加以患者为中心的治疗模式来提高治疗依从性和结果
    • 治疗运动障碍的微创手术技术的高需求
    • 扩大旨在减轻运动障碍症状的新疗法的管道
  • 市场限制因素
    • 深度治疗费用高
  • 市场机会
    • 创新的治疗性介入可改善运动障碍患者的运动表现和生活品质
    • 用于运动障碍早期检测和进展监测的先进诊断工具和技术
    • 结合药物和非药理学的处置方法治疗运动障碍的个人化治疗计划
  • 市场挑战
    • 严格监管要求的副作用

波特的五力:驾驭运动障碍市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势,解决弱点并避免潜在的挑战,从而确保更强大的市场地位。

PESTLE分析:了解运动障碍市场的外在影响

外在宏观环境因素在塑造运动障碍市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素,公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化,并帮助他们做出积极主动的决策。

市场占有率分析 了解运动障碍市场的竞争格局

对运动障碍市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势,为供应商提供了製定策略决策所需的洞察力,使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵运动障碍市场厂商绩效评估

FPNV 定位矩阵是评估运动障碍市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商,从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商,并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製运动障碍市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说,对运动障碍市场的策略分析至关重要。透过审查关键资源、能力和绩效指标,公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战,利用新的商机,并取得长期成功。

本报告对市场进行了全面分析,涵盖关键重点领域:

1. 市场渗透率:对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓:辨识新兴市场的成长机会,评估现有领域的扩张潜力,并提供未来成长的策略蓝图。

3. 市场多元化:分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报:彻底分析竞争格局,检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新:重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题,以帮助相关人员做出明智的决策:

1.目前的市场规模和未来的成长预测是多少?

2. 哪些产品、区隔市场和地区提供最佳投资机会?

3.塑造市场的主要技术趋势和监管影响是什么?

4.主要厂商的市场占有率和竞争地位如何?

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 製药公司与研究机构的合作
      • 增加以病人为中心的照护模式,以提高治疗顺从性和结果
      • 治疗运动障碍的微创手术技术的高需求
      • 扩大旨在减轻运动障碍症状的新疗法的管道
    • 抑制因素
      • 深度治疗费用高
    • 机会
      • 创新的治疗性介入可改善运动障碍患者的运动功能和生活品质
      • 用于早期检测和监测运动障碍进展的先进诊断工具和技术
      • 结合药物和非药理学的处置方法治疗运动障碍的个人化治疗计划
    • 任务
      • 严格的监管要求和药物副作用
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章运动障碍市场:依类型

  • 舞蹈病
  • 左旋多巴引起的运动障碍
  • 肌阵挛
  • 口腔面部运动障碍
  • 阵发性运动障碍
  • 迟发性运动障碍

第七章运动障碍市场的治疗

  • 药品
    • 抗胆碱能药物
    • 麸胺酸阻断剂
    • 单胺转运调节剂
  • 外科手术
    • 消融技术
    • 脑深部电刺激疗法
  • 治疗方法
    • 职能治疗
    • 物理治疗
    • 语言治疗

第八章运动障碍市场:依给药途径

  • 可注射的
  • 口服
  • 经皮吸收贴片

第九章运动障碍市场:依最终用户分类

  • 学术研究所
  • 居家护理
  • 医院
  • 专科诊所

第10章美洲运动障碍市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太运动障碍市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲运动障碍市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵,2023
  • 竞争场景分析
  • 战略分析和建议
Product Code: MRR-535C6291879B

The Dyskinesia Market was valued at USD 2.34 billion in 2023, expected to reach USD 2.50 billion in 2024, and is projected to grow at a CAGR of 8.44%, to USD 4.13 billion by 2030.

Dyskinesia, often associated with Parkinson's disease and similar disorders, refers to involuntary, erratic, and writhing movements of muscles. Its scope covers a wide range of conditions, including drug-induced dyskinesia primarily linked to long-term use of medications like levodopa. The necessity for addressing dyskinesia arises from its significant impact on patients' quality of life, making research and treatment imperative. The application scope primarily includes pharmaceuticals targeting neurotransmitter systems and therapeutic devices offering symptom relief. Key end-use sectors include hospitals, clinics, and research institutions. Market growth is driven by rising prevalence of neurological disorders, increasing awareness, and advancements in medical technology. However, the high cost of treatment and side effects associated with existing therapies pose significant growth challenges. Innovations in personalized medicine and gene therapy offer promising avenues for development and could significantly impact market dynamics. Present opportunities lie within the development of non-dopaminergic treatment options and wearable monitoring technology for real-time symptom tracking. For businesses, actively engaging in partnerships with research institutions to pioneer cutting-edge treatments and implementing AI-driven research strategies could prove advantageous. A crucial recommendation is investing in comprehensive clinical trials to substantiate the efficacy and safety of new interventions. Challenges like regulatory hurdles and stringent approval processes often slow down market entry of novel therapies. Furthermore, the heterogeneity of patient responses to treatment necessitates more personalized approaches, which can complicate standardization efforts. Geographic disparities in treatment availability underscore the importance of expanding reach in emerging markets. The best areas for innovation include neuroprotective strategies and the exploration of microbiome-gut interactions affecting neurodegeneration. Overall, the dyskinesia market is poised for growth, particularly as new innovations address existing limitations, yet it requires strategic navigation of the inherent complexities and challenges to realize full potential.

KEY MARKET STATISTICS
Base Year [2023] USD 2.34 billion
Estimated Year [2024] USD 2.50 billion
Forecast Year [2030] USD 4.13 billion
CAGR (%) 8.44%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Dyskinesia Market

The Dyskinesia Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Collaborative efforts between pharmaceutical companies and research institutions
    • Increase in patient-centric care models enhancing treatment adherence and outcomes
    • High demand for minimally invasive surgical techniques for treating dyskinesia
    • Expanding pipeline of novel therapeutic agents aimed at mitigating dyskinesia symptoms
  • Market Restraints
    • High costs of advanced treatments
  • Market Opportunities
    • Innovative therapeutic interventions for enhancing mobility and quality of life in dyskinesia patients
    • Advanced diagnostic tools and technologies for early detection and monitoring of dyskinesia progression
    • Personalized treatment plans integrating pharmacological and non-pharmacological approaches for dyskinesia management
  • Market Challenges
    • Adverse medication effects along with stringent regulatory requirements

Porter's Five Forces: A Strategic Tool for Navigating the Dyskinesia Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Dyskinesia Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Dyskinesia Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Dyskinesia Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Dyskinesia Market

A detailed market share analysis in the Dyskinesia Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Dyskinesia Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Dyskinesia Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Dyskinesia Market

A strategic analysis of the Dyskinesia Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Dyskinesia Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Acadia Pharmaceuticals Inc., Acorda Therapeutics, Inc., Adamas Pharmaceuticals, Inc., Amneal Pharmaceuticals, Inc., BioArctic AB, GlaxoSmithKline plc, Intra-Cellular Therapies, Inc., Ipsen Pharma, Kyowa Kirin Co., Ltd., Lundbeck A/S, Medtronic plc, Merz Pharmaceuticals GmbH, Neurocrine Biosciences, Inc., Roche Holding AG, Sage Therapeutics, Inc., Sunovion Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Ultragenyx Pharmaceutical Inc., and Voyager Therapeutics, Inc..

Market Segmentation & Coverage

This research report categorizes the Dyskinesia Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Chorea, Levodopa-Induced Dyskinesia, Myoclonus, Orofacial Dyskinesia, Paroxysmal Dyskinesias, and Tardive Dyskinesia.
  • Based on Treatment, market is studied across Medications, Surgical Procedures, and Therapies. The Medications is further studied across Anticholinergics, Glutamate Blockers, and Monoamine Transport Modifiers. The Surgical Procedures is further studied across Ablative Techniques and Deep Brain Stimulation. The Therapies is further studied across Occupational Therapy, Physical Therapy, and Speech Therapy.
  • Based on Route of Administration, market is studied across Injectable, Oral, and Transdermal Patches.
  • Based on End User, market is studied across Academic & Research Institutes, Homecare, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Collaborative efforts between pharmaceutical companies and research institutions
      • 5.1.1.2. Increase in patient-centric care models enhancing treatment adherence and outcomes
      • 5.1.1.3. High demand for minimally invasive surgical techniques for treating dyskinesia
      • 5.1.1.4. Expanding pipeline of novel therapeutic agents aimed at mitigating dyskinesia symptoms
    • 5.1.2. Restraints
      • 5.1.2.1. High costs of advanced treatments
    • 5.1.3. Opportunities
      • 5.1.3.1. Innovative therapeutic interventions for enhancing mobility and quality of life in dyskinesia patients
      • 5.1.3.2. Advanced diagnostic tools and technologies for early detection and monitoring of dyskinesia progression
      • 5.1.3.3. Personalized treatment plans integrating pharmacological and non-pharmacological approaches for dyskinesia management
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse medication effects along with stringent regulatory requirements
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Dyskinesia Market, by Type

  • 6.1. Introduction
  • 6.2. Chorea
  • 6.3. Levodopa-Induced Dyskinesia
  • 6.4. Myoclonus
  • 6.5. Orofacial Dyskinesia
  • 6.6. Paroxysmal Dyskinesias
  • 6.7. Tardive Dyskinesia

7. Dyskinesia Market, by Treatment

  • 7.1. Introduction
  • 7.2. Medications
    • 7.2.1. Anticholinergics
    • 7.2.2. Glutamate Blockers
    • 7.2.3. Monoamine Transport Modifiers
  • 7.3. Surgical Procedures
    • 7.3.1. Ablative Techniques
    • 7.3.2. Deep Brain Stimulation
  • 7.4. Therapies
    • 7.4.1. Occupational Therapy
    • 7.4.2. Physical Therapy
    • 7.4.3. Speech Therapy

8. Dyskinesia Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Injectable
  • 8.3. Oral
  • 8.4. Transdermal Patches

9. Dyskinesia Market, by End User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Homecare
  • 9.4. Hospitals
  • 9.5. Specialty Clinics

10. Americas Dyskinesia Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Dyskinesia Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Dyskinesia Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Acadia Pharmaceuticals Inc.
  • 3. Acorda Therapeutics, Inc.
  • 4. Adamas Pharmaceuticals, Inc.
  • 5. Amneal Pharmaceuticals, Inc.
  • 6. BioArctic AB
  • 7. GlaxoSmithKline plc
  • 8. Intra-Cellular Therapies, Inc.
  • 9. Ipsen Pharma
  • 10. Kyowa Kirin Co., Ltd.
  • 11. Lundbeck A/S
  • 12. Medtronic plc
  • 13. Merz Pharmaceuticals GmbH
  • 14. Neurocrine Biosciences, Inc.
  • 15. Roche Holding AG
  • 16. Sage Therapeutics, Inc.
  • 17. Sunovion Pharmaceuticals Inc.
  • 18. Teva Pharmaceutical Industries Ltd.
  • 19. Ultragenyx Pharmaceutical Inc.
  • 20. Voyager Therapeutics, Inc.

LIST OF FIGURES

  • FIGURE 1. DYSKINESIA MARKET RESEARCH PROCESS
  • FIGURE 2. DYSKINESIA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DYSKINESIA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DYSKINESIA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DYSKINESIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DYSKINESIA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DYSKINESIA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DYSKINESIA MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DYSKINESIA MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DYSKINESIA MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DYSKINESIA MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DYSKINESIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DYSKINESIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DYSKINESIA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DYSKINESIA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DYSKINESIA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DYSKINESIA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DYSKINESIA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DYSKINESIA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DYSKINESIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DYSKINESIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DYSKINESIA MARKET DYNAMICS
  • TABLE 7. GLOBAL DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DYSKINESIA MARKET SIZE, BY CHOREA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DYSKINESIA MARKET SIZE, BY LEVODOPA-INDUCED DYSKINESIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DYSKINESIA MARKET SIZE, BY MYOCLONUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DYSKINESIA MARKET SIZE, BY OROFACIAL DYSKINESIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DYSKINESIA MARKET SIZE, BY PAROXYSMAL DYSKINESIAS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DYSKINESIA MARKET SIZE, BY TARDIVE DYSKINESIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DYSKINESIA MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DYSKINESIA MARKET SIZE, BY ANTICHOLINERGICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DYSKINESIA MARKET SIZE, BY GLUTAMATE BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DYSKINESIA MARKET SIZE, BY MONOAMINE TRANSPORT MODIFIERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DYSKINESIA MARKET SIZE, BY ABLATIVE TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DYSKINESIA MARKET SIZE, BY DEEP BRAIN STIMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DYSKINESIA MARKET SIZE, BY THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DYSKINESIA MARKET SIZE, BY OCCUPATIONAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DYSKINESIA MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DYSKINESIA MARKET SIZE, BY SPEECH THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL DYSKINESIA MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL DYSKINESIA MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL DYSKINESIA MARKET SIZE, BY TRANSDERMAL PATCHES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL DYSKINESIA MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL DYSKINESIA MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL DYSKINESIA MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL DYSKINESIA MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. AMERICAS DYSKINESIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. ARGENTINA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. BRAZIL DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 66. CANADA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 73. MEXICO DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. UNITED STATES DYSKINESIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC DYSKINESIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. AUSTRALIA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 103. CHINA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. INDIA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. INDONESIA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 124. JAPAN DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 131. MALAYSIA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. PHILIPPINES DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 145. SINGAPORE DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 152. SOUTH KOREA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 159. TAIWAN DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 166. THAILAND DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 173. VIETNAM DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA DYSKINESIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 188. DENMARK DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 195. EGYPT DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 202. FINLAND DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 209. FRANCE DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 216. GERMANY DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 223. ISRAEL DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 230. ITALY DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 237. NETHERLANDS DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 244. NIGERIA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 251. NORWAY DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 258. POLAND DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 265. QATAR DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 272. RUSSIA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 279. SAUDI ARABIA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 286. SOUTH AFRICA DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 293. SPAIN DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 300. SWEDEN DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 307. SWITZERLAND DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 314. TURKEY DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED ARAB EMIRATES DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY MEDICATIONS, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2030 (USD MILLION)
  • TABLE 326. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 327. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 328. UNITED KINGDOM DYSKINESIA MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 329. DYSKINESIA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 330. DYSKINESIA MARKET, FPNV POSITIONING MATRIX, 2023